InvestorsHub Logo
Followers 126
Posts 28941
Boards Moderated 0
Alias Born 01/21/2006

Re: cabel post# 70004

Friday, 09/19/2014 9:00:50 AM

Friday, September 19, 2014 9:00:50 AM

Post# of 402424
Maybe he said something else in the R&R talk...this is what I could find...

Aug 19 PR..."The company expects data from the trial to be available in the fourth quarter of 2014."

http://finance.yahoo.com/news/cellceutix-completes-enrollment-phase-2b-123000703.html


Sept. 9 PR..."Cellceutix will not know the actual cure rates per treatment arm until the data is unblinded in October/November. However, the Company is very optimistic and views the high average cure rate on the blinded data as a very good sign for Brilacidin. Assuming positive results after unblinding, Cellceutix will have proven that Brilacidin is a safe and effective drug in the Phase 2 trial, and all activities will be triggered for initiation of a pivotal Phase 3 trial."

http://finance.yahoo.com/news/cellceutix-provides-initial-observations-completed-190000867.html




Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News